Skip to main content

Advertisement

SpringerLink
Log in

Recommendations of the Spanish Brachytherapy Group of SEOR for HDR endoluminal treatments. Part 1: Oesophagus

  • Clinical Guides in Oncology
  • Published:
Clinical and Translational Oncology Aims and scope Submit manuscript

Abstract

The endoesophageal brachytherapy technique provides good results in the treatment of oesophageal cancer, when indicated. In a consensus meeting, the Spanish Brachytherapy Group of SEOR and the Spanish Society of Medical Physics (SEFM) agreed on the indications, dose, fractionation schedule, prescription and reporting to be performed in endoesophageal brachytherapy. The results of this consensus are presented here as recommendations for medical practice.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Czito BG, Denitis AS, Willet CG. Esophageal cancer. In: Halperin EC, Perez CA, Brady LW, editors. Perez and Brady’s principles and practice of radiation oncology. Chapter 50, 5nd edn. Philadelphia: Lippincott Williams and Wilkins Ed.; 2008. p. 1131–53.

  2. Homs MY, Steyerberg EW, Eijkenboom WM, Tilanus HW, Stalpers LJ, Bartelsman JF, et al. Single-dose brachytherapy versus metal stent placement for the palliation of dysphagia from oesophageal cancer: multicenter randomised trial. Lancet. 2004;364:1497–504.

    Article  PubMed  Google Scholar 

  3. Guisez LE, Barçat P. Essais de traitement de quelques cas d’epithéliome de l’oesophage par les aplications locales directes du radium. Bull Soc Med des hôpitaux Paris. 1909;26:717–22.

    Google Scholar 

  4. Oesophageal Carcinoma. In: Strnad V, Potter R, Kovacs G, editors. Practical handbook of brachytherapy, 1st edn. London: UNI-MED Verlag AG, International Medical Publishers; 2014. p. 211–17.

  5. Potter R, Van Limbergen E. Oesophageal cancer. In: Gerbaulet A, Potter R, Mazeron JJ, Meertens H, Van Limbergen E, editors. The GEC ESTRO handbook of brachytherapy. Leuven: ACCO Ed.; 2002. p. 515–37.

  6. Lopez-Carrizosa C, Menendez JC, Rovirosa A. Cancer de Esófago. In: EnGuinot JL, Lanzós E, Muñoz V, Polo A, Ramos A, editors. Guía de braquiterapia de la SEOR. Madrid: Medical Practice Group Ed.; 2008. p. 417–423.

  7. Maigon P, D’Hombres A, Truc G, Barillot I, Michiels C, Bedenne L, et al. High dose rate brachytherapy for superficial cancer of the esophagus. Int J Radiat Oncol Biol Phys. 2000;46:71–6.

    Article  Google Scholar 

  8. Nemoto K, Yamada S, Hareyama M, Nagakura H, Hirokawa Y. Radiation therapy for superficial esophageal cancer: a comparison of radiotherapy methods. Int J Radiat Oncol Bio Phys. 2001;50:639–44.

    Article  CAS  Google Scholar 

  9. Murakami Y, Nagata Y, Nishibuchi I, Kimura T, Kenjo M, Kaneyasu Y, et al. Long-term outcomes of intraluminal brachytherapy in combination with external beam radiotherapy for superficial esophageal cancer. Int J Clin Oncol. 2012;17:263–71.

    Article  PubMed  Google Scholar 

  10. Ishikawa H, Sakurai H, Tamaki Y, Nonaka T, Yamakawa M, Saito Y, et al. Radiation therapy alone for stage I (UICC T1N0M0) squamous cell carcinoma of esophagus: indications for surgery or combines chemoradiotherapy. Am J Gastroenterol Hepatol. 2006;21:1290–6.

    Article  Google Scholar 

  11. Ishikawa H, Sakurai H, Yamakawa M, Saito Y, Nakayama Y, Kitamoto Y, et al. Clinical outcomes and prognostic factors for patients with earlier esophageal squamous cell carcinoma treated with definitive radiation therapy alone. J Clin Gastroenterol. 2005;39:495–500.

    Article  PubMed  Google Scholar 

  12. Murakami M, Kuroda Y, Nakajima T, Okamoto Y, Mizowaki T, Kusumi F, et al. Comparison between chemoradiation protocol intended for organ preservation and conventional surgery for clinical T1–T2 esophageal carcinoma. Int J Radiat Oncol Biol Phys. 1999;45:277–84.

    Article  CAS  PubMed  Google Scholar 

  13. Okawa T, Dokiya T, Nishio M, Hishikawa Y, Morita K. Multi-institutional randomized trial of external radiotherapy with and without intraluminal brachytherapy for esophageal cancer in Japan. Japanese Society of Therapeutic Radiology and Oncology (JASTRO) Study Group. Int J Radiat Oncol Biol Phys. 1999;1(45):623–8.

    Article  Google Scholar 

  14. Sai H, Mitsumori M, Araki A. Long term results of definitive radiotherapy for stage I esophageal cancer. Int J Radiat Oncol Biol Phys. 2005;62:1339–44.

    Article  PubMed  Google Scholar 

  15. Ishikawa H, Nonaka T, Sakurai H, Tamaki Y, Kitamoto Y, Ebara T, et al. Usefulness of intraluminal brachytherapy combined with external beam radiation therapy for submucosal esophageal cancer: long-term follow-up results. Int J Radiat Oncol Biol Phys. 2010;76:452–9.

    Article  PubMed  Google Scholar 

  16. Kodaira T, Fuwa N, Tachibana H, Nakamura T, Tomita N, Nakahara R, et al. Retrospective analysis of definitive radiotherapy for patients with superficial esophageal carcinoma: consideration of the optimal treatment method with a focus on late morbidity. Radiother Oncol. 2010;95:234–9.

    Article  PubMed  Google Scholar 

  17. Tamaki T, Ishikawa H, Takahashi T, Tamaki Y, Kitamoto Y, Okamoto M, et al. Comparison of efficacy and safety of low-dose-rate vs. high-dose-rate intraluminal brachytherapy boost in patients with superficial esophageal cancer. Brachytherapy. 2012;11:130–6.

    Article  PubMed  Google Scholar 

  18. Hishikawa Y, Taniguchi M, Kamikonya N, Tanaka S, Miura T. Radiation treatment of superficial spreading carcinoma of esophagus. Radiat Med. 1989;7:42–5.

    CAS  PubMed  Google Scholar 

  19. Yamada K, Murakami M, Okamoto Y, Okuno Y, Nakajima T, Kusumi F, et al. Treatment results of chemoradiotherapy for clinical stage I (T1N0M=) esophageal carcinoma. Int J Radiat Oncol Biol Phys. 2006;64:1106–11.

    Article  PubMed  Google Scholar 

  20. Shioyama Y, Nakamura K, Sasaki T, Ooga S, Urashima Y, Kimura M, et al. Clinical results of radiation therapy for stage I esophageal cáncer: a single institutional experience. Am J Clin Oncol. 2005;28(1):75–80.

    Article  PubMed  Google Scholar 

  21. Yorozu A, Dokiya T, Oki Y. High dose rate brachytherapy boost following concurrent chemoradiotherapy for esophageal carcinoma. Int J Radiat Oncol Biol Phys. 1999;45:271–5.

    Article  CAS  PubMed  Google Scholar 

  22. Taieb S, Vaillant E, Pommier P, Bonvoisin S, Desseigne F, Morignat E, et al. Curative treatment of non metastatic esophageal cancer: concomitant chemoradiotherapy and high dose rate endoluminal curietherapy boost. Gastroenterol Clin Biol. 1999;23:1048–54.

    CAS  PubMed  Google Scholar 

  23. Vuong T, Szego P, David M, Evans M, Parent J, Mayrand S, et al. The safety and usefulness of high-dose-rate endoluminal brachytherapy as a boost in the treatment of patients with esophageal cancer with external beam radiation with or without chemotherapy. Int J Radiat Oncol Biol Phys. 2005;63:758–64.

    Article  PubMed  Google Scholar 

  24. Mujis C, Beukema J, Mul V, Plukker JT, Sijtsema NM, Langendijk JA. External beam radiotherapy combined with intraluminal brachytherapy in esophageal carcinoma. Radiother Oncol. 2012;102:303–8.

    Article  Google Scholar 

  25. Lopez Carrizosa MC, Samper OTS, Rodríguez Perez A, Sotoca A, Sáez Garrido J, de Miguel MM. High dose rate brachytherapy (HDR-BT) in locally advanced oesophageal cancer. Clinic response and survival related to biological equivalent dose (BED). Clin Transl Oncol. 2007;9:385–91.

    Article  PubMed  Google Scholar 

  26. Someya M, Sakata K, Saito A, Nagakura H, Oouchi A, Hareyama M. Results of external irradiation and low-dose-rate intraluminal brachytherapy for esophageal cancer. Acta Oncol. 2002;41:63–8.

    Article  PubMed  Google Scholar 

  27. Taal BG, Aleman BM, Koning CC, Boot H. High dose rate brachytherapy before external beam irradiation in inoperable oesophageal cancer. Br J Cancer. 1996;74:1452–7.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  28. Rovirosa A, Marsiglia H, Lartigau E, Zimmermann P, Chirat E, Delapierre M, et al. Endoluminal high dose rate brachytherapy with a palliative aim in esophageal cáncer: preliminary results at the Institut Gustave Roussy. Tumori. 1995;8:359–63.

    Google Scholar 

  29. Castilla L, Rovirosa A, Ginès A, Pages M, Camacho C, Quilis C, et al. Braquiterapia endoluminal esofágica en el tratamiento del cáncer de esófago: descripción de la técnica a propósito de un caso, y revisión de la literatura. Revista española de Enfermedades digestivas. 2015, aceptado, en prensa.

  30. Sur RK, Donde B, Levin VC, Mannell A. Fractionated high dose rate intraluminal brachytherapy in palliation of advanced esophageal cancer. Int J Radiat Oncol Biol Phys. 1998;40:447–53.

    Article  CAS  PubMed  Google Scholar 

  31. Sur RK, Levin CV, Donde B, Sharma V, Miszczyk L, Nag S. Prospective randomized trial of HDR brachytherapy as a sole modality in palliation of advanced esophageal carcinoma—an International Atomic Energy Agency study. Int J Radiat Oncol Biol Phys. 2002;53:127–33.

    Article  PubMed  Google Scholar 

  32. Sur R, Donde B, Levin VC. Prospective randomized trial comparing high dose rate intraluminal brachytherapy (HDRILBT) alone with HDRILBT and external beam radiotherapy in the palliation of advanced oesophageal cancer. Int J Brachytherapy. 2004;3:191–5.

    Article  Google Scholar 

  33. Bergquist H, Wenger U, Johnsson E, Nyman J, Ejnell H, Hammerlid E. Stent insetion or endoluminal brachytherapy as palliation of patients with advanced cáncer of the esophagus and gastroesophageal junction. Results of a randomized, controlled clinical trial. Dis Esophagus. 2005;18:131–9.

    Article  CAS  PubMed  Google Scholar 

  34. Skowronek J, Piotrowski T, Zwierzchowski G. Palliative treatment by high dose rate intraluminal brachytherapy in patients with advanced esophageal cancer. Brachytherapy. 2004;3:87–94.

    Article  PubMed  Google Scholar 

  35. Rosenblatt E, Jones G, Sur R, Donde B, Salvajoli JV, Ghosh-Laskar S. Adding external beam to intra-luminal brachytherapy improves palliation in obstructive squamous cell oesophageal cancer: a prospective multi-centre randomized trial of the International Atomic Energy Agency. Radiother Oncol. 2010;97:488–94.

    Article  PubMed  Google Scholar 

  36. Spencer GM, Thorpe SM, Blackman GM, Solano J, Tobias JS, Lovat LB. Laser augmented by brachytherapy versus laser alone in the palliation of adenocarcinoma of the oesophagus and cardia: a randomised study. Gut. 2002;50:224–7.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  37. Eldeeb H, Reza S, Shmueli U, Logsdail G, Hinks P, Mukherjee S. External beam radiotherapy in the management of malignant oesophageal dysphagia: a retrospective study. JBUON. 2012;17:508–11.

    CAS  PubMed  Google Scholar 

  38. Bergquist H, Johnsson E, Nyman J, Rylander H, Hammerlid E, Friesland S, et al. Combined stent insertion and single high-dose brachytherapy in patients with advanced esophageal cancer- results of a prospective safety study. Dis Esophagus. 2012;25:410–5.

    Article  CAS  PubMed  Google Scholar 

  39. Lettmaier S, Strnad V. Intraluminal brachytherapy in oesophageal cancer: defining its role and introducing the technique. J Comtemporary Brachytherapy. 2014;6:236–41.

    Article  Google Scholar 

  40. Gaspar LE, Nag S, Herskovic A, Mantravadi R, Speicer B. American brachytherapy Society guidelines for brachytherapy of oesophageal cancer. Int J Radiat Oncol Biol Phys. 1997;38:127–32.

    Article  CAS  PubMed  Google Scholar 

  41. Pasquier D, Mirabel X, Adenis A, Rezvoy N, Hecquet G, Fournier C, et al. External beam radiation therapy followed by high-dose-rate brachytherapy for inoperable superficial esophageal carcinoma. Int J Radiat Oncol Biol Phys. 2006;1(65):1456–61.

    Article  Google Scholar 

  42. Hujala K, Sipila J, Minn H, Ruotsalainen P, Grenmann R. Combined external and intraluminal radiotherapy in the treatment of advanced esophageal cancer. Radiother Oncol. 2002;64:41–5.

    Article  PubMed  Google Scholar 

  43. Calais G, Dorval E, Louisot P, Bourlier P, Klein V, Chapet S, et al. Radiotherapy with high dose rate brachytherapy boost and concomitant chemotherapy for stages IIB and III oesophageal carcinoma: results of a pilot study. Int J Radiat Oncol Biol Phys. 1997;38:769–75.

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgments

We thank all the attendees at the meeting, physicians and physicists, both members and non-members of SEOR and members of SEFM, for their participation and their contributions to the debate with the aim of reaching consensus beyond divergent opinions.

Conflict of interest

The authors declare that they have no conflict of interest.

Author information

Authors and Affiliations

  1. Radiation Oncology Department, ICMHO, Hospital Clínic I Universitari, C/Villarroel 170, 08036, Barcelona, Spain

    Á. Rovirosa & A. Herreros

  2. Radiation Oncology Department, Hospital Marqués de Valdecilla, Santander, Spain

    J. Anchuelo & J. C. Menéndez

  3. Radiation Oncology Department, Instituto Valenciano de Oncologia, Valencia, Spain

    V. Crispin

  4. Radiation Oncology Department, Institut Català d’Oncologia, Hospitalet de Llobregat, Catalonia, Spain

    C. Gutiérrez & P. Pino

  5. Radiation Oncology Department, Hospital Carlos Haya, Málaga, Spain

    I. Herruzo

  6. Radiation Oncology Department, Hospital Ramon y Cajal, Madrid, Spain

    A. Polo

  7. Radiation Oncology Department, Hospital Clínica Benidorm, Benidorm, Spain

    S. Rodríguez

Authors
  1. Á. Rovirosa
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. J. Anchuelo
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. V. Crispin
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. C. Gutiérrez
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. A. Herreros
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. I. Herruzo
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. J. C. Menéndez
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. P. Pino
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. A. Polo
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. S. Rodríguez
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Á. Rovirosa.

Additional information

On behalf of the Spanish Brachytherapy Group of the SEOR (Sociedad Española de Oncología Radioterápica) and SEFM (Sociedad Española de Física Médica).

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Rovirosa, Á., Anchuelo, J., Crispin, V. et al. Recommendations of the Spanish Brachytherapy Group of SEOR for HDR endoluminal treatments. Part 1: Oesophagus. Clin Transl Oncol 17, 581–589 (2015). https://doi.org/10.1007/s12094-015-1284-0

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12094-015-1284-0

Keywords

Search

Navigation